Related Experiment Video

Updated: May 19, 2026

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
12:00

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro

Published on: July 5, 2017

Effect of dietary polyphenols on K562 leukemia cells: a Foodomics approach

Alberto Valdés1, Carolina Simó, Clara Ibáñez

  • 1Laboratory of Foodomics, CIAL (CSIC), Madrid, Spain.

Electrophoresis
|August 14, 2012
PubMed

Insights

Rosemary polyphenols show antiproliferative effects on leukemia cells by altering gene expression and metabolite profiles. These compounds may offer differential chemopreventive benefits, potentially inhibiting Myc transcription factor activity.

Area of Science:

  • * Foodomics and Nutrigenomics
  • * Cancer Biology and Chemoprevention
  • * Molecular Biology and Metabolomics

Background:

  • * Leukemia is a significant health concern, necessitating novel therapeutic strategies.
  • * Dietary polyphenols, like those in rosemary, are recognized for their potential health benefits.
  • * Understanding the molecular mechanisms of chemopreventive agents is crucial for drug development.

Purpose of the Study:

  • * To investigate the antiproliferative effects of rosemary polyphenols on drug-sensitive and drug-resistant human leukemia cell lines.
  • * To elucidate the molecular mechanisms underlying these effects using a Foodomics approach.
  • * To explore the differential impact of rosemary polyphenols on leukemia cells with varying drug resistance phenotypes.

Main Methods:

  • * Employed a global Foodomics strategy integrating transcriptomics and metabolomics.
  • * Utilized whole-transcriptome microarray for gene expression analysis.
  • * Applied mass spectrometry-based nontargeted approaches (CE-TOF MS, UPLC-TOF MS) for metabolomics.
  • * Performed functional enrichment analysis using Ingenuity Pathway Analysis (IPA) software.

Main Results:

  • * Rosemary polyphenols altered approximately 1% of gene expression in both leukemia cell lines.
  • * Observed differential induction of phase II detoxifying and antioxidant genes.
  • * Identified distinct metabolic profiles in response to rosemary polyphenols between the two cell lines.
  • * IPA analysis suggested inhibition of Myc transcription factor by rosemary polyphenols.

Conclusions:

  • * Rosemary polyphenols exhibit antiproliferative effects on human leukemia cells.
  • * The study suggests a differential chemopreventive effect of rosemary polyphenols based on leukemia cell phenotype.
  • * Inhibition of Myc transcription factor activity is a potential mechanism for the observed antiproliferative effects.
  • * Integrated transcriptomics and metabolomics data provide evidence for modulated metabolic pathways.

More Related Videos

Assessment of the Metabolic Profile of Primary Leukemia Cells06:21

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

Simultaneous Quantification of Selected Kynurenines Analyzed by Liquid Chromatography-Mass Spectrometry in Medium Collected from Cancer Cell Cultures10:38

Simultaneous Quantification of Selected Kynurenines Analyzed by Liquid Chromatography-Mass Spectrometry in Medium Collected from Cancer Cell Cultures

Published on: May 9, 2020

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...